CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

CA Cancer J Clin 2001; 51:232
doi: 10.3322/canjclin.51.4.232
© 2001 American Cancer Society
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow An erratum has been published
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rhodes, V. A.
Right arrow Articles by McDaniel, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rhodes, V. A.
Right arrow Articles by McDaniel, R. W.

Nausea, Vomiting, and Retching: Complex Problems in Palliative Care

Verna A. Rhodes, EdS and Roxanne W. McDaniel, PhD

Ms. Rhodes is an Associate Professor at Sinclair School of Nursing, University of Missouri, Columbia, MO.
Dr. McDaniel is an Associate Professor at Sinclair School of Nursing, University of Missouri, Columbia, MO.

Patients with advanced cancer commonly experience nausea, vomiting, and/or retching (NVR) as a result of the malignant process and its treatment. Recently, increasing attention is being focused on end-of-life care, which includes relief or reduction of symptoms such as NVR.

Pre-chemotherapy preparation and patient education in the palliative care setting are essential to preventing acute and delayed distress from NVR, as well as anticipatory symptoms. Careful assessment of chemotherapy-related symptoms should distinguish between the three phenomena rather than taking a global approach. Strategies for preventing anticipatory nausea, for instance, may differ significantly from those designed to reduce frequency of vomiting.

Management of anticancer treatment-related NVR should incorporate both pharmacologic and nonpharmacologic approaches, whenever appropriate, with the overall goal of improving and/or maintaining the patient’s quality of life.




This article has been cited by other articles:


Home page
 cfpHome page
C. O'Brien
Nausea and vomiting
Can Fam Physician, June 1, 2008; 54(6): 861 - 863.
[Full Text] [PDF]

Home page
 JAMAHome page
G. J. Wood, J. W. Shega, B. Lynch, and J. H. Von Roenn
Management of Intractable Nausea and Vomiting in Patients at the End of Life: "I Was Feeling Nauseous All of the Time . . . Nothing Was Working"
JAMA, September 12, 2007; 298(10): 1196 - 1207.
[Abstract] [Full Text] [PDF]

Home page
 Palliat MedHome page
C. Saxby, R. Ackroyd, S. Callin, C. Mayland, and S. Kite
How should we measure emesis in palliative care?
Palliative Medicine, July 1, 2007; 21(5): 369 - 383.
[Abstract] [PDF]

Home page
 Palliat MedHome page
M Henderson, E MacGregor, N Sykes, and M Hotopf
The use of benzodiazepines in palliative care
Palliative Medicine, June 1, 2006; 20(4): 407 - 412.
[Abstract] [PDF]

Home page
 The OncologistHome page
F. M. Schnell
Chemotherapy-Induced Nausea and Vomiting: The Importance of Acute Antiemetic Control
Oncologist, April 1, 2003; 8(2): 187 - 198.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
T. Ades, T. Gansler, and H. Eyre
Communicating with Patients about Quality of Life Issues
CA Cancer J Clin, July 1, 2001; 51(4): 211 - 212.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by American Cancer Society.